Back To Search Results

Caprini Score

Editor: Kristine Song Updated: 6/2/2025 11:40:09 PM

Summary / Explanation

Venous thromboembolism (VTE), which encompasses disorders such as deep vein thrombosis and pulmonary embolism, comprises a significant and frequently underdiagnosed complication among hospitalized patients. Despite its prevalence, VTE is largely preventable through appropriate risk assessment and targeted prophylactic interventions. Implementing standardized protocols for VTE prevention is essential to reduce its incidence and the associated morbidity and mortality.[1]

The Caprini Score

The Caprini Score is a validated risk assessment tool designed to estimate a patient’s likelihood of developing VTE. Originally developed in 1991 for surgical patients, the Caprini Score has since been updated multiple times, with the most recent comprehensive revision published in 2013. This predictive model assigns points to various risk factors related to the Virchow Triad—venous stasis, endothelial injury, and hypercoagulability—based on their presence currently or within the past month.[2] Notably, the Caprini Score uniquely includes family history of VTE and pregnancy loss as independent risk factors.

The 2013 Caprini Risk Assessment Model stratifies patients into 4 risk categories based on total points:

  • Low risk: 0 to 1 point
  • Moderate risk: 2 points
  • High risk: 3 to 4 points
  • Very high risk: at least 5 points

This stratification guides clinicians in tailoring VTE prophylaxis strategies according to individual patient risk (see Table. Caprini Risk Assessment Model 2013).[3] The classification incorporates a wide range of risk factors, such as age, recent surgery, malignancy, obesity (body mass index or BMI ≥25), smoking, insulin-dependent diabetes, chemotherapy, blood transfusions, and prolonged surgery duration (>2 hours). Female-specific factors include current hormone therapy and pregnancy-related risks.

Points from all applicable categories are added to calculate the total Caprini Score. Risk stratification and prophylaxis planning are determined based on the total score. Female-specific factors should be applied only to female patients where indicated.

Table. Caprini Risk Assessment Model 2013

Points

Risk Factor

1 point each
  • Age 41–60 years
  • Planned minor surgery <45 minutes
  • Major surgery in the past month >45 minutes
  • Visible varicose veins
  • History of inflammatory bowel disease (eg, Crohn disease)
  • Swollen legs (current)
  • BMI ≥25
  • Heart attack
  • Congestive heart failure
  • Serious infection (eg, pneumonia)
  • Existing lung disease (eg, COPD)
  • Bed rest or reduced mobility <72 hours

For women only:

  • Hormone use (eg, oral contraceptives or hormone replacement therapy)
  • Pregnancy or postpartum state within 1 month
  • Unexplained stillbirth, recurrent spontaneous abortion (>3), premature birth with preeclampsia or growth-restricted infant

Other risk factors:

  • BMI >40
  • Smoking
  • Diabetes requiring insulin
  • Chemotherapy
  • Blood transfusions
  • Surgery lasting more than 2 hours
2 points each
  • Age 61–74 years
  • Malignancy, present or past, excluding nonmelanoma skin cancer
  • Planned major surgery (>45 minutes), including laparoscopic and arthoscopic procedures
  • Immobilizing plaster cast for the past month
  • Central venous access within the last month
  • Bed rest ≥72 hours
3 points each
  • Age ≥75 years
  • History of VTE (DVT or pulmonary embolism)
  • Family history of VTE
  • Personal or family history of a known thrombophilia (eg, Factor V Leiden)
5 points each
  • Elective hip or knee arthroplasty
  • Hip, pelvis, or leg fracture
  • Serious trauma (eg, multiple fractures)
  • Spinal cord injury leading to paralysis
  • Stroke

Prophylaxis Recommendations Based on Risk Level

The Caprini Score informs decisions regarding VTE prevention but does not itself prescribe prophylaxis. Instead, this score estimates VTE risk, and prophylaxis is selected accordingly.

  • Low risk (0-1 points): Early ambulation is generally sufficient. No pharmacologic or mechanical prophylaxis is typically required.

  • Moderate risk (2 points): Mechanical prophylaxis (eg, intermittent pneumatic compression devices) or pharmacologic prophylaxis may be considered based on clinical context.

  • High risk (3-4 points): Pharmacologic prophylaxis is recommended during hospitalization, with mechanical methods added if appropriate.

  • Very high risk (≥5 points): Combined pharmacologic and mechanical prophylaxis is advised, often with extended pharmacologic prophylaxis postdischarge (7-10 days). In some cases, patients with scores above 8 may benefit from longer prophylaxis, usually up to 30 days.

Early identification of high-risk patients using the Caprini Score allows timely intervention with anticoagulant and mechanical prophylaxis. This approach not only improves acute outcomes but also helps prevent chronic complications that may occur even after appropriately treated acute VTE, such as recurrent VTE, postthrombotic syndrome, and chronic pulmonary hypertension.[4][5] Since prophylactic anticoagulation carries risks, particularly bleeding, accurate identification of patients who genuinely need prophylaxis is essential.

The Caprini Score must be regularly reassessed throughout hospitalization or postoperative recovery. Shifts in a patient’s clinical status may alter the total score, prompting adjustments in prophylactic management.

Clinical Impact and Validation

The Caprini Score has been validated internationally in over 5 million patients in more than 250 clinical trials. This tool helps identify individuals at risk for VTE, guiding timely, personalized prophylaxis that reduces VTE events and long-term complications. The integration of the Caprini Score into hospital protocols has led to measurable reductions in hospital-associated VTE and better patient outcomes.

Conclusion

The Caprini Risk Assessment Model is a validated method for evaluating VTE risk in hospitalized and surgical patients. By quantifying factors related to venous stasis, endothelial injury, and hypercoagulability, this system enables the interprofessional team to implement timely, risk-based prophylaxis. Routine use fosters coordinated care, enhances patient safety, and reduces preventable VTE-related morbidity and mortality across healthcare settings.

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

References


[1]

Tafur AJ, Caprini JA. Dissecting the rationale for thromboprophylaxis in challenging surgical cases. Journal of thrombosis and haemostasis : JTH. 2024 Mar:22(3):613-619. doi: 10.1016/j.jtha.2023.12.033. Epub 2024 Jan 4     [PubMed PMID: 38184204]

Level 3 (low-level) evidence

[2]

Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. American journal of surgery. 2010 Jan:199(1 Suppl):S3-10. doi: 10.1016/j.amjsurg.2009.10.006. Epub     [PubMed PMID: 20103082]


[3]

Cronin M, Dengler N, Krauss ES, Segal A, Wei N, Daly M, Mota F, Caprini JA. Completion of the Updated Caprini Risk Assessment Model (2013 Version). Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2019 Jan-Dec:25():1076029619838052. doi: 10.1177/1076029619838052. Epub     [PubMed PMID: 30939900]


[4]

Gu ZC, Zhang C, Yang Y, Wang MG, Li HY, Zhang GY. Prediction Model of in-Hospital Venous Thromboembolism in Chinese Adult Patients after Hernia Surgery: The CHAT Score. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2021 Jan-Dec:27():10760296211051704. doi: 10.1177/10760296211051704. Epub     [PubMed PMID: 34928746]


[5]

Wilson S, Chen X, Cronin M, Dengler N, Enker P, Krauss ES, Laberko L, Lobastov K, Obi AT, Powell CA, Schastlivtsev I, Segal A, Simonson B, Siracuse J, Wakefield TW, McAneny D, Caprini JA. Thrombosis prophylaxis in surgical patients using the Caprini Risk Score. Current problems in surgery. 2022 Nov:59(11):101221. doi: 10.1016/j.cpsurg.2022.101221. Epub 2022 Sep 24     [PubMed PMID: 36372452]